Winchester David E, Pepine Carl J
North Florida/South Georgia Veterans Health System, Gainesville, FL, USA; Division of Cardiovascular Medicine, University of Florida, 1600 S.W. Archer Rd., PO Box 100277, Gainesville, FL 32610-0277, USA.
Division of Cardiovascular Medicine , University of Florida , 1600 S.W. Archer Rd., PO Box 100277, Gainesville, FL 32610-0277 , USA.
Eur Heart J Suppl. 2015 Dec;17(Suppl G):G10-G18. doi: 10.1093/eurheartj/suv054. Epub 2015 Dec 16.
Angina pectoris is the symptomatic manifestation of transient myocardial ischaemia. At the most fundamental level, angina arises when myocardial oxygen demand exceeds the ability of the coronary circulation to provide adequate oxygen delivery to maintain normal myocardial metabolic function. , the balance of oxygen demand and delivery is a complex physiological process that can be altered by a variety of interventions. Lifestyle modification is a cornerstone of cardiovascular disease management, with or without angina. Additional pharmaceutical and physical interventions are usually applied to patients with angina. Mechanisms of action for these interventions include heart rate modulation, vascular smooth muscle relaxation, metabolic manipulation, revascularization, and others. A number of these interventions have overlapping mechanisms that target angina. Additionally, some interventions may directly or indirectly prevent or delay adverse outcomes such as myocardial infarction or death. This review summarizes current evidence for many applied ischaemia treatments documented to modify angina and comments on available evidence relating to improvement in cardiovascular outcomes.
心绞痛是短暂性心肌缺血的症状表现。在最基本的层面上,当心肌需氧量超过冠状动脉循环提供足够氧输送以维持正常心肌代谢功能的能力时,就会出现心绞痛。 氧供需平衡是一个复杂的生理过程,可通过多种干预措施改变。生活方式的改变是心血管疾病管理的基石,无论是否有心绞痛。通常会对心绞痛患者采用额外的药物和物理干预措施。这些干预措施的作用机制包括心率调节、血管平滑肌舒张、代谢调控、血运重建等。其中许多干预措施具有针对心绞痛的重叠机制。此外,一些干预措施可能直接或间接预防或延迟不良后果,如心肌梗死或死亡。本综述总结了目前许多已记录的用于改善心绞痛的缺血治疗的证据,并对与心血管结局改善相关的现有证据进行了评论。